David D. Headrick is a Shareholder at McAndrews with deep experience in intellectual property (IP) litigation and advising clients on strategic IP matters. David has tried and litigated many cases, some involving more than $2 billion in accused products. He is recognized by IAM Patent 1000, and according to IAM’s sources, “There’s nobody better to have by your side in strategic negotiations, critical conflict resolution or bet-the-company litigation than David.”

David’s practice also includes IP licensing, clearance opinions, IP due diligence, and patent and trademark procurement.

Examples of David’s work include:

• Defending a client when a competitor sought an emergency injunction against the client’s highest revenue-generating product and $1.2 billion in damages where the court denied the injunction, granted summary judgment, and awarded $5 million in fees.
• Defending a client from a competitor’s patent infringement claims against $180 million in sales where David’s team petitioned for inter partes review of the asserted patents, stayed the underlying case, and ultimately invalidated 80 of the competitor’s claims (leading to a nominal settlement).
• Securing a $166 million victory for a large client (this case ranked in the top ten U.S. patent infringement awards for several years).
• Advising a medical device client in its $130 million acquisition of a company specializing in metal and synthetic products in the orthopedics, biologics, spine, trauma, and cardiothoracic markets.
• Guiding a consumer electronics client through the IP issues involved in its $72 million acquisition of a well-known electronic toy manufacturer.

David also has extensive experience with contested proceedings in the U.S. Patent Office and foreign patent jurisdictions (where he works closely with foreign counsel to defend clients’ global interests).

In transactional work, David has advised many clients on IP acquisition, divestiture, and licensing deals valued in the hundreds of millions of dollars.

David’s experience encompasses a broad spectrum of technologies, including coronary angioplasty catheters, coronary stent systems, cardiac defibrillators/pacemakers, allograft surgical implants, bone cleaning and processing technology, mesenchymal stem cells, Wi-Fi and video encoding technology, digital electronics, software/operating systems, and needleless injection sites.